Epaned FDA Approval History
FDA Approved: Yes (First approved August 13, 2013)
Brand name: Epaned
Generic name: enalapril maleate
Dosage form: Oral Solution
Company: Azurity Pharmaceuticals
Treatment for: High Blood Pressure, Heart Failure, Left Ventricular Dysfunction
Epaned (enalapril maleate) is an angiotensin-converting enzyme inhibitor indicated for the treatment of hypertension in adults and children older than one month, symptomatic heart failure, and asymptomatic left ventricular dysfunction.
Development Timeline for Epaned
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.